Marcus E. Randall, MD, FACR, FASTRO

Chair, Department of Radiation Medicine
Chief of Ambulatory Services

Practice areas

Practice areas

Clinical interests

  • General Radiation Oncology
  • Gynecologic Malignancies

Marcus E. Randall, MD, FACR, FASTRO

Chair, Department of Radiation Medicine
Chief of Ambulatory Services

Biography

My name is Marcus E. Randall; I received my medical degree from the University of North Carolina at Chapel Hill, School of Medicine and completed a residency in Radiation Oncology at the University of Virginia, Charlottesville. I am board certified by the American Board of Radiology and a Fellow of the American College of Radiology and American Society for Therapeutic Radiology and Oncology. I am a national leader in gynecologic radiation oncology.

Within the Gynecologic Oncology Group, I have led national trials in endometrial and ovarian cancers, chaired the Radiation Oncology Committee, and co-chair the Uterine Corpus Committee. I am the Radiation Oncology editor of the world's leading multi-disciplinary textbook for gynecologic cancers, Principles and Practice of Gynecologic Oncology, now in its 6th edition.

Faculty rank

Professor of Radiation Medicine

Education

Degree
MD, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill

Residency
University of Virginia Medical Center, Charlottesville

Certifications or Special training
American Board of Radiology
Fellow of the American College of Radiology
Fellow of the American Society for Therapeutic Radiology and Oncology

Gynecologic Oncology

Gynecologic Oncology Clinic

Markey Cancer Center
Whitney-Hendrickson Building
Third Floor, Room 330A
800 Rose St.
Lexington KY 40536-0098

Call 859-323-5553
Call 866-340-4488
Fax 859-323-1602

Directions to Markey Cancer Center »



Radiation Medicine

UK Albert B. Chandler Hospital - Pavilion H
Ground Floor
800 Rose St.
Lexington KY 40536-0293

Call 859-323-6486
Call 859-323-6487
Fax 859-257-4931

Amenities
ATM, Dining, Gift shop, Information desk, Post office

Directions to UK Albert B. Chandler Hospital - Pavilion H Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Randall K, Stevens J, Yepes JF, Randall ME, Kudrimoti M, Feddock J, Xi J, Kryscio RJ, Miller CS. Analysis of factors influencing the development of xerostomia during intensity-modulated radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):772-9.
    View in: PubMed
  2. Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012 Dec 1; 131(11):2519-27. PMID: 22447412.
    View in: PubMed
  3. Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, Monk BJ, Randall ME. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Apr; 125(1):87-93. PMID: 22155678.
    View in: PubMed
  4. Podzielinski I, Randall ME, Breheny PJ, Escobar PF, Cohn DE, Quick AM, Chino JP, Lopez-Acevedo M, Seitz JL, Zook JE, Seamon LG. Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. Gynecol Oncol. 2012 Jan; 124(1):36-41. PMID: 22015042.
    View in: PubMed
  5. Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC, Pachtman S, Podzielinski I, Branscum AJ, Feddock JM, Randall ME, Desimone CP. Cervical cancer survival for patients referred to a tertiary care center in Kentucky. Gynecol Oncol. 2011 Dec; 123(3):565-70. PMID: 21963092.
    View in: PubMed
  6. Shah PH, Kudrimoti M, Feddock J, Randall M. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies. Gynecol Oncol. 2011 Sep; 122(3):675-83. PMID: 21664661.
    View in: PubMed
  7. Moore KN, Tian C, McMeekin DS, Thigpen JT, Randall ME, Gallion HH. Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis. Cancer. 2010 Dec 1; 116(23):5407-14. PMID: 20737572.
    View in: PubMed
  8. Feddock J, Kudrimoti M, Randall M. No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer. Expert Rev Anticancer Ther. 2010 Jul; 10(7):1087-100. PMID: 20645698.
    View in: PubMed
  9. Miller DS, Fleming G, Randall ME. Chemo- and radiotherapy in adjuvant management of optimally debulked endometrial cancer. J Natl Compr Canc Netw. 2009 May; 7(5):535-41. PMID: 19460279.
    View in: PubMed
  10. Small W, Du Bois A, Bhatnagar S, Reed N, Pignata S, Potter R, Randall M, Mirza M, Trimble E, Gaffney D. Practice patterns of radiotherapy in endometrial cancer among member groups of the gynecologic cancer intergroup. Int J Gynecol Cancer. 2009 Apr; 19(3):395-9. PMID: 19407566.
    View in: PubMed
  11. Fakiris AJ, Randall ME. Endometrial carcinoma: the current role of adjuvant radiation. J Obstet Gynaecol. 2009 Feb; 29(2):81-9. PMID: 19274535.
    View in: PubMed
  12. Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH, Fleming GF. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol. 2007 Apr; 105(1):59-65. PMID: 17150247.
    View in: PubMed
  13. Bruner DW, Barsevick A, Tian C, Randall M, Mannel R, Cohn DE, Sorosky J, Spirtos NM. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Qual Life Res. 2007 Feb; 16(1):89-100. PMID: 17033909.
    View in: PubMed
  14. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006 Jan 1; 24(1):36-44. PMID: 16330675.
    View in: PubMed
  15. Shaeffer DT, Randall ME. Adjuvant radiotherapy in endometrial carcinoma. Oncologist. 2005 Sep; 10(8):623-31. PMID: 16177286.
    View in: PubMed
  16. Fakiris AJ, Moore DH, Reddy SR, Look KY, Yiannoutsos CT, Randall ME, Cardenes HR. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study. Gynecol Oncol. 2005 Mar; 96(3):818-23. PMID: 15721431.
    View in: PubMed
  17. Cardenes H, Randall ME. Is observation and salvage (when necessary) an appropriate approach to intermediate risk endometrial cancer? Gynecol Oncol. 2003 May; 89(2):199-200. PMID: 12713980.
    View in: PubMed
  18. McCormick TC, Cardenes H, Randall ME. Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy? Brachytherapy. 2002; 1(2):61-5. PMID: 15062172.
    View in: PubMed
  19. Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol. 1999 Nov; 75(2):211-4. PMID: 10525373.
    View in: PubMed
  20. Cardenes H, Randall ME. Clarity and confusion regarding adjuvant radiation therapy in early endometrial cancer. Gynecol Oncol. 1999 Oct; 75(1):1-3. PMID: 10502416.
    View in: PubMed
  21. Wolfson AH, Tralins KS, Greven KM, Kim RY, Corn BW, Kuettel MR, Philippart C, Raub WA, Randall ME. Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients. Int J Radiat Oncol Biol Phys. 1998 Jan 1; 40(1):71-6. PMID: 9422560.
    View in: PubMed
  22. Randall ME, Spirtos NM, Dvoretsky P. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122. J Natl Cancer Inst Monogr. 1995; (19):13-5. PMID: 7577198.
    View in: PubMed
  23. Sears JD, Greven KM, Hoen HM, Randall ME. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer. 1994 Aug 15; 74(4):1303-8. PMID: 8055452.
    View in: PubMed
  24. Randall ME, Reisinger S. Radiation therapy and combined chemo-irradiation in advanced and recurrent endometrial carcinoma. Semin Oncol. 1994 Feb; 21(1):91-9. PMID: 8310315.
    View in: PubMed
  25. Sigmon WR, Randall ME, Olds WW, McCunniff AJ, St Clair WH, Craven TE. Increased chronic bowel complications with split-course pelvic irradiation. Int J Radiat Oncol Biol Phys. 1994 Jan 15; 28(2):349-53. PMID: 8276649.
    View in: PubMed
  26. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence. Cancer. 1993 Jun 1; 71(11):3697-702. PMID: 8490920.
    View in: PubMed
  27. Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM. Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol. 1993 Jan; 48(1):23-31. PMID: 8423018.
    View in: PubMed
  28. Randall ME, Evans L. Issues in gynecologic radiation oncology. Curr Opin Oncol. 1991 Oct; 3(5):920-9. PMID: 1751583.
    View in: PubMed
  29. Lanciano RM, Curran WJ, Greven KM, Fanning J, Stafford P, Randall ME, Hanks GE. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990 Dec; 39(3):368-73. PMID: 2258085.
    View in: PubMed
  30. Greven KM, Curran WJ, Whittington R, Fanning J, Randall ME, Wilder J, Peters AJ. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications. Int J Radiat Oncol Biol Phys. 1989 Jul; 17(1):35-9. PMID: 2745205.
    View in: PubMed
  31. Kersh CR, Randall ME, Constable WC, Hahn SS, Taylor PT, Krebs HB, Goplerud DR. Whole abdominal radiotherapy following cytoreductive surgery and chemotherapy in ovarian carcinoma. Gynecol Oncol. 1988 Sep; 31(1):113-21. PMID: 3410342.
    View in: PubMed
  32. Randall ME, Barrett RJ. Interstitial irradiation in the management of recurrent carcinoma of the cervix after previous radiation therapy. N C Med J. 1988 Jun; 49(6):306-8. PMID: 3135500.
    View in: PubMed
  33. Randall ME, Andersen WA, Mills SE, Kim JA. Papillary squamous cell carcinoma of the uterine cervix: a clinicopathologic study of nine cases. Int J Gynecol Pathol. 1986; 5(1):1-10. PMID: 3957549.
    View in: PubMed